Browsing by Author "Gathright, Y"

Now showing 1 - 1 of 1
  • Thumbnail Image
    Item
    Molecular alterations in primary prostate cancer after androgen ablation therapy
    (AMER ASSOC CANCER RESEARCH, 2005) Best, CJM; Gillespie, JW; Yi, YJ; Chandramouli, GVR; Perlmutter, MA; Gathright, Y; Erickson, HS; Georgevich, L; Tangrea, MA; Duray, PH; Gonzalez, S; Velasco, A; Linehan, WM; Matusik, RJ; Price, DK; Figg, WD; Emmert Buck, MR; Chuaqui, RF
    Purpose: After an initial response to androgen ablation, most prostate tumors recur, ultimately progressing to highly aggressive androgen-independent cancer. The molecular mechanisms underlying progression are not well known in part due to the rarity of androgen-independent Samples from primary and-metastatic sites.